President Donald Trump said on Monday that China is ready to come back to the negotiating table and the two countries will start talking very seriously.Politicsread more
The escalating trade war between Washington and Beijing dominated discussions at the G-7 gathering in France.Politicsread more
The latest round of tariff announcements in the last few days means that by the end of the year, essentially all Chinese goods exported to the U.S. will be subject to duties.China Economyread more
Futures fell after Trump said the U.S. will raise tariffs on more than $500 billion worth of Chinese imports, increasing trade tensions.Marketsread more
As Washington and Beijing continue to up the ante in their protracted trade fight, the potential of a recession in the U.S. is now "the biggest concern," according to Standard...US Economyread more
Tensions stemming from the U.S.-China trade war escalated sharply over the last few days, with much happening as Asian markets were shut down for the weekend.China Economyread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
Neither the U.S. nor China wants to be seen as the party that derailed trade talks, says William Reinsch of Center for Strategic and International Studies.World Economyread more
China said Friday it will be resuming 25% duties on U.S. autos, and a further 5% on auto parts and components.Asia Marketsread more
World leaders, environmental groups and celebrities have publicly decried the vast swaths of forest being destroyed by the fires.World Newsread more
Education Minister Ong Ye Kung says the Singapore government has been preparing for the challenge of an aging workforce "for the past 20 years."Employmentread more
The Securities and Exchange Commission is reportedly conducting three investigations into whether leaks from the federal agency that runs the massive Medicare program led to stock moves on Wall Street in advance of regulatory actions by that agency.
The SEC has questioned almost a dozen officials with the Centers for Medicare and Medicaid Services as part of the insider-trading probes, one of which also involves the Federal Bureau of Investigation, The Wall Street Journal reported in a front-page story Wednesday.
The newspaper reported that subpoenas have been served on stocks traders, government officials and research firms that specialize in Medicare policy.
Medicare, federal government's health-insurance for the elderly and disabled, is responsible for a significant share of overall U.S. health spending, with a $600 billion budget. CMS, which also operates the Obamacare program, is a division of the U.S. Health and Human Services Department.
The Journal's story begins with an anecdote recounting how on June 7, 2010, shares of the company Dendreon, plummeted 10 percent within hours of CMS officials beginning private discussions on whether to set limits on how much Medicare would pay for Dendreon's prostate cancer treatment Provenge.
Two of the SEC probes are related to Dendreon's continued stock drops in advance of a June 30, 2010, formal announcement by CMS that it was reviewing whether to continue reimbursing the full $93,000 cost-per-patient treatment for Provenge, the Journal reported.
An ex-CMS official named David Blaszczak, known for making accurate predictions about Medicare payment rules, is the focus in one investigation, according to the Journal.
Blaszczak denied any wrongdoing to the paper.
The Journal said the third probe involving the FBI as well is eyeing whether CMS brass tipped off a policy research firm and a health-care lobbyist to still-private plans to increase funding for health-insurance firms.
The full story can be read here: Insider Probe Focuses on Medicare Agency.